Cargando…
Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T‐cell lymphoma
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763404/ https://www.ncbi.nlm.nih.gov/pubmed/27402335 http://dx.doi.org/10.1002/hon.2320 |
| _version_ | 1783291880389214208 |
|---|---|
| author | Pro, Barbara Horwitz, Steven M. Prince, H. Miles Foss, Francine M. Sokol, Lubomir Greenwood, Matthew Caballero, Dolores Morschhauser, Franck Wilhelm, Martin Iyer, Swaminathan Padmanabhan Shustov, Andrei R. Wolfson, Julie Balser, Barbara E. Coiffier, Bertrand |
| author_facet | Pro, Barbara Horwitz, Steven M. Prince, H. Miles Foss, Francine M. Sokol, Lubomir Greenwood, Matthew Caballero, Dolores Morschhauser, Franck Wilhelm, Martin Iyer, Swaminathan Padmanabhan Shustov, Andrei R. Wolfson, Julie Balser, Barbara E. Coiffier, Bertrand |
| author_sort | Pro, Barbara |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5763404 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-57634042018-01-17 Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T‐cell lymphoma Pro, Barbara Horwitz, Steven M. Prince, H. Miles Foss, Francine M. Sokol, Lubomir Greenwood, Matthew Caballero, Dolores Morschhauser, Franck Wilhelm, Martin Iyer, Swaminathan Padmanabhan Shustov, Andrei R. Wolfson, Julie Balser, Barbara E. Coiffier, Bertrand Hematol Oncol Letters to the Editor John Wiley and Sons Inc. 2016-07-12 2017-12 /pmc/articles/PMC5763404/ /pubmed/27402335 http://dx.doi.org/10.1002/hon.2320 Text en © 2016 The Authors Hematological Oncology Published by John Wiley & Sons Ltd This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters to the Editor Pro, Barbara Horwitz, Steven M. Prince, H. Miles Foss, Francine M. Sokol, Lubomir Greenwood, Matthew Caballero, Dolores Morschhauser, Franck Wilhelm, Martin Iyer, Swaminathan Padmanabhan Shustov, Andrei R. Wolfson, Julie Balser, Barbara E. Coiffier, Bertrand Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T‐cell lymphoma |
| title | Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T‐cell lymphoma |
| title_full | Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T‐cell lymphoma |
| title_fullStr | Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T‐cell lymphoma |
| title_full_unstemmed | Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T‐cell lymphoma |
| title_short | Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T‐cell lymphoma |
| title_sort | romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic t‐cell lymphoma |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763404/ https://www.ncbi.nlm.nih.gov/pubmed/27402335 http://dx.doi.org/10.1002/hon.2320 |
| work_keys_str_mv | AT probarbara romidepsininducesdurableresponsesinpatientswithrelapsedorrefractoryangioimmunoblastictcelllymphoma AT horwitzstevenm romidepsininducesdurableresponsesinpatientswithrelapsedorrefractoryangioimmunoblastictcelllymphoma AT princehmiles romidepsininducesdurableresponsesinpatientswithrelapsedorrefractoryangioimmunoblastictcelllymphoma AT fossfrancinem romidepsininducesdurableresponsesinpatientswithrelapsedorrefractoryangioimmunoblastictcelllymphoma AT sokollubomir romidepsininducesdurableresponsesinpatientswithrelapsedorrefractoryangioimmunoblastictcelllymphoma AT greenwoodmatthew romidepsininducesdurableresponsesinpatientswithrelapsedorrefractoryangioimmunoblastictcelllymphoma AT caballerodolores romidepsininducesdurableresponsesinpatientswithrelapsedorrefractoryangioimmunoblastictcelllymphoma AT morschhauserfranck romidepsininducesdurableresponsesinpatientswithrelapsedorrefractoryangioimmunoblastictcelllymphoma AT wilhelmmartin romidepsininducesdurableresponsesinpatientswithrelapsedorrefractoryangioimmunoblastictcelllymphoma AT iyerswaminathanpadmanabhan romidepsininducesdurableresponsesinpatientswithrelapsedorrefractoryangioimmunoblastictcelllymphoma AT shustovandreir romidepsininducesdurableresponsesinpatientswithrelapsedorrefractoryangioimmunoblastictcelllymphoma AT wolfsonjulie romidepsininducesdurableresponsesinpatientswithrelapsedorrefractoryangioimmunoblastictcelllymphoma AT balserbarbarae romidepsininducesdurableresponsesinpatientswithrelapsedorrefractoryangioimmunoblastictcelllymphoma AT coiffierbertrand romidepsininducesdurableresponsesinpatientswithrelapsedorrefractoryangioimmunoblastictcelllymphoma |